Navigation Links
BioCrossroads Commemorates Decade of Collaboration, Success for Indiana Life Sciences Sector
Date:2/14/2012

INDIANAPOLIS, Feb. 13, 2012 /PRNewswire/ -- Ten years ago today, a task force comprised of Indianapolis business, academic and civic leaders came together to develop a strategy for Indiana's life sciences sector that would catapult the state's legacy of strong life sciences companies and research institutions into a 21st-century hub for biotechnology and medical technology. Known today as BioCrossroads, that strategy has driven the state into the national spotlight as a leader and destination in biotechnology, medical devices and healthcare information technology.

"With major players like WellPoint, Eli Lilly and Company, Cook, Roche and Indiana University School of Medicine calling Indiana home, we knew we had worthy assets to build an economy of scale," said David Johnson, president and CEO of BioCrossroads. "But 10 years ago, those remarkable entities weren't collaborating, or in some cases even talking to each other, so we knew we needed a catalyst to make bigger things happen for Indiana."

Initially, BioCrossroads (originally called the Central Indiana Life Sciences Initiative) was tasked to spur life sciences research, generate more investment dollars, and attract more talent to build on the remarkable base of leading life sciences companies and research institutions already residing in the state. BioCrossroads started as a Central Indiana-based initiative, but over the past decade has spread throughout the state making significant--and measurable--progress on the original goals.

A "success story" according to an industry report in 2011, BioCrossroads has raised more than one-quarter billion dollars in philanthropic grant funds and capital investments to start and support life sciences opportunities.  BioCrossroads has also organized four venture capital and seed-stage investment funds, launched eight new enterprises like the Indiana Health Information Exchange, the Fairbanks Institute for Healthy Communities, and OrthoWo
'/>"/>

SOURCE BioCrossroads
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioCrossroads Awards Indiana Life Sciences Leaders
2. Two-year $2.8 million Grant from Lilly Endowment Fuels BioCrossroads Charitable, Educational and Scientific Mission
3. BioCrossroads Invests in Innovative Biotech Targeting Challenging Diseases
4. Orthopedics Entrepreneur Named BioCrossroads Watanabe Life Sciences Champion of the Year
5. BioCrossroads Invests in Indianapolis Biotech Company Developing Treatments for Alzheimers Disease
6. BioCrossroads Indiana Seed Fund Invests in Vaccine Biotech Company
7. 40 Years on the Leading Edge: Case Western Reserve Universitys Biomedical Engineering Department Commemorates Achievement, Looks to Future
8. Thomson Reuters Commemorates World IP Week with Series of Strategic Intellectual Property Seminars Across the U.S.
9. Decades-old conclusion about energy-making pathway of cyanobacteria is corrected
10. New study indicates smallpox vaccination effective for decades
11. You: Being Beautiful Authors Mehmet Oz, MD, & Michael Roizen, MD, Call Ribose One of the Decades Real Nutritional Heroes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014 Regulus ... biopharmaceutical company leading the discovery and development of innovative ... financial results and highlights for the quarter ended June ... U.S. financial markets close. Regulus will ... 6, 2014, at 5:00 pm Eastern Daylight Time to ...
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron Pharmaceuticals, ... SNY) today announced that the Companies intend to use ... disease priority review voucher in connection with the Biologics ... voucher entitles the holder to designate a BLA for ... from the filing date instead of the standard 10-month ...
(Date:7/30/2014)... W. R. Grace & Co. (NYSE: ... REVELERIS® Prep purification system , a dual-mode instrument ... researchers to perform both flash and preparative liquid ... the REVELERIS® Prep purification system, researchers can easily ... a simple touch of the screen, giving them ...
(Date:7/30/2014)... July 30, 2014  Decision Resources Group finds ... directors in the United States ... market penetration will be the level of savings ... the expected lower cost to patients. Payers plan ... meet their pricing expectations in order to encourage ...
Breaking Biology Technology:Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6Grace Launches New REVELERIS® Prep Purification System 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3
... GAMMAGARD LIQUID and GAMMAGARD S/D, [Immune Globulin Intravenous ... Ill., Aug. 22 Baxter International,Inc. (NYSE: ... GARDian, an innovative,program that helps provide continued access ... [Immune Globulin Intravenous (Human)],(IGIV). IGIV products like GAMMAGARD ...
... 22 ATS Medical, Inc.,(Nasdaq: ATSI ), ... services, today announced that the US Food and ... begin marketing,additional sizes of its line of ATS ... http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ) Michael Dale, Chairman and Chief ...
... New Ballot Initiative to Pursue Cures for Patients, ... without involving controversial Human Cloning, WASHINGTON, Aug. 22 ... ensure that taxpayer funds,support cures for patients, without involving human ... issued the,following statement on the new initiative, Cures Without Cloning. ...
Cached Biology Technology:Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 2Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 3Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 4Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 5Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 6Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 7Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 8Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 9ATS Medical Expands Open Pivot Heart Valve Offerings 2
(Date:7/30/2014)... by the Red Queen in Lewis Carroll,s Through ... Illinois and National University of Singapore improved a ... evolve over decades to millions of years. , ... for competition, incorporates the "Red Queen Effect," an ... the 1970s, which suggests that organisms must constantly ...
(Date:7/30/2014)... octopus protected and tended her eggs until they hatched ... 30, 2014 in the open-access journal PLOS ONE ... Institute and colleagues. , Octopuses typically have a single ... and take care of their fertilized eggs until they ... 1 to 3 months, but little is known about ...
(Date:7/30/2014)... American Chemical Society (ACS) announced today that David L. ... ACS Biomaterials Science & Engineering as editor-in-chief. With ... the new journal will feature high-quality research in the ... or naturally derived materials that interact with living or ... it reflects the tremendous growth in the field of ...
Breaking Biology News(10 mins):Classic Lewis Carroll character inspires new ecological model 2Classic Lewis Carroll character inspires new ecological model 3Deep-sea octopus has longest-known egg-brooding period 2ACS Biomaterials Science & Engineering: Brand-new journal launches in 2015, names editor 2
... are closing in on finding an effective bait to ... beetle, which is now killing not only lodgepole pine ... and Canada Research Chair in Forest Entomology in the ... investigating pheromones emitted by the pest in North America,s ...
... of New England (Australia) and the Royal Botanic Gardens ... species of sedge from south-western Tasmania. A small clumping ... mountains including Mount Field and Mount Sprent. It is ... essentially restricted to alpine vegetation. At less than seven ...
... professor is developing a comprehensive data system that can ... by providing them with access to chemical toxicity information. ... is building the "automated profiling system" from existing bioassay ... profiles can help scientists who are seeking information on ...
Cached Biology News:Bait research focused on outsmarting destructive beetle 2Tasmania home to first alpine sword-sedge 2Toxicity database under development at Rutgers-Camden 2